Paper
RSC Advances
6 M. Arisawa, T. Ono and M. Yamaguchi, Tetrahedron Lett.,
2005, 46, 5669.
Conflicts of interest
7 For examples, (a) M. Arisawa, T. Tazawa, W. Ichinose,
H. Kobayashi and M. Yamaguchi, Adv. Synth. Catal., 2018,
360, 3488; (b) M. Arisawa, T. Yamada, S. Tanii, Y. Kawada,
H. Hashimoto and M. Yamaguchi, Chem. Commun., 2016,
52, 13580; (c) M. Arisawa and M. Yamaguchi, Tetrahedron
Lett., 2010, 51, 4840.
8 Y. Zhou, S. Yin, Y. Gao, Y. Zhao, M. Goto and L.-B. Han,
Angew. Chem., Int. Ed., 2010, 49, 6852.
9 J. Michalski, W. Stec and A. Zwierzak, Chem. Ind., 1965, 8,
347.
There are no conicts to declare.
Acknowledgements
This research was supported by the Platform Project for Sup-
porting Drug Discovery and Life Science Research from AMED
under Grant number JP18am0101100, JSPS KAKENHI Grant
number 17K19112, and Tohoku University Center for Gender
Equality Promotion (TUMUG).
10 For
examples
of
nucleophilic
substitution,
(a)
Notes and references
C. M. Timperley, S. A. Saunders, J. Szpalek and
M. J. Waters, J. Fluorine Chem., 2003, 119, 161; (b)
P.-Y. Renard, H. Schwebel, P. Vayron, L. Josien, A. Valleix
and C. Mioskowski, Chem.–Eur. J., 2002, 8, 2910; (c)
T.-L. Au-Yeung, K.-Y. Chan, W.-K. Chan, R. K. Haynes,
I. D. Williams and L. L. Yeung, Tetrahedron Lett., 2001, 42,
453; (d) R. G. Harvey, H. I. Jacobson and E. V. Jensen, J.
Am. Chem. Soc., 1963, 85, 1623.
1 For examples, (a) S. Li, L. Wang, F. Yu, Z. Zhu, D. Shobaki,
H. Chen, M. Wang, J. Wang, G. Qin, U. J. Erasquin, L. Ren,
Y. Wang and C. Cai, Chem. Sci., 2017, 8, 2107; (b) J. Martell
and E. Weerapana, Molecules, 2014, 19, 1378; (c)
S. I. Presolski, V. P. Hong and M. G. Finn, Curr. Protoc.
Chem. Biol., 2011, 3, 153.
2 For examples, (a) J. Ohata, M. B. Minus, M. E. Abernathy and
Z. T. Ball, J. Am. Chem. Soc., 2016, 138, 7472; (b) S. D. Tilley
and M. B. Francis, J. Am. Chem. Soc., 2006, 128, 1080; (c)
J. M. Antos and M. B. Francis, J. Am. Chem. Soc., 2004, 126,
10256; (d) Review: E. M. Sletten and C. R. Bertozzi, Angew.
Chem., Int. Ed., 2009, 48, 6974.
3 For examples, (a) G. D'Alessio, M. C. Maloni and A. Parente,
Biochemistry, 1975, 14, 1116; (b) D. L. Sondack and A. Light, J.
Biol. Chem., 1971, 246, 1630; (c) P. A. Price, W. H. Stein and
S. Moore, Disulde bridged modication of proteins via
reduction, J. Biol. Chem., 1969, 244, 929; (d) Review:
S. L. Kuan, T. Wang and T. Weil, Chem.–Eur. J., 2016, 22,
17112; (e) S. Brocchini, A. Godwin, S. Balan, J. Choi,
M. Zloh and S. Shaunak, Adv. Drug Delivery Rev., 2008, 60, 3.
4 M. Arisawa, A. Suwa and M. Yamaguchi, J. Organomet. Chem.,
2006, 691, 1159.
11 For examples of oxidative coupling of thiols and
phosphonates, (a) H. Huang, J. Ash and J. Y. Kang, Org.
Biomol. Chem., 2018, 16, 4236; (b) S. Song, Y. Zhang,
A. Yeerlan, B. Zhu, J. Liu and N. Jiao, Angew. Chem., Int.
Ed., 2017, 56, 2487; (c) Y. Moon, Y. Moon, H. Choi and
S. Hong, Green Chem., 2017, 19, 1005.
12 Using phosphorothioates, (a) D. J. Jones, E. M. O'Leary and
T. P. O'Sullivan, Tetrahedron Lett., 2018, 59, 4279; (b)
X.-Y. Chen, M. Pu and H.-G. Cheng, Angew. Chem., Int. Ed.,
2019, 58, 11395; (c) X. Zhang, Z. Shi, C. Shao, J. Zhao,
D. Wang, G. Zhang and L. Li, Eur. J. Org. Chem., 2017, 1884.
13 (a) M. J. Piggott and P. V. Attwood, Amino Acids, 2017, 49,
1309; (b) J. Bertran-Vicente, M. Penkert, O. Nieto-Garcia,
J.-M. Jeckelmann, P. Schmieder, E. Krause and
C. P. R. Hackenderger, Nat. Commun., 2016, 7, 12703; (c)
A. K. Buchowiecka, Amino Acids, 2019, 51, 1365.
5 M. Arisawa, M. Kuwajima, A. Suwa and M. Yamaguchi,
Heterocycles, 2010, 80, 1239.
This journal is © The Royal Society of Chemistry 2020
RSC Adv., 2020, 10, 13820–13823 | 13823